Clinical Trials Logo

Clinical Trial Summary

PCOS is a common and complex disease affecting women of reproductive age. It is characterized by its complex pathological symptoms and mechanisms resulting in endocrine and metabolic dysfunction. PCOS is highly associated with various metabolic and endocrinal disorders. Metformin is mainly used for its glucose-lowering effects for treatment and prevention of type-2 diabetes mellitus (DM), gestational DM, and PCOS. Myo-inositol (MI) protects against MAFLD through reduction of hepatic accumulation of triglycerides.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06170463
Study type Interventional
Source Zagazig University
Contact
Status Completed
Phase Phase 1
Start date August 1, 2022
Completion date April 15, 2023